<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="topic" /><meta name="keywords" content="Immunosuppressants: transplant rejection; Transplant rejection" /><meta name="IX" content="Immunosuppressants: transplant rejection; Transplant rejection" /><title>Immunosuppressant therapy: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="100044.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="100044.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=100044.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4777.htm">8.2 Drugs affecting the immune response</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="4777.htm" title="Previous: 8.2 Drugs affecting the immune response">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4778.htm" title="Next: 8.2.1 Antiproliferative immunosuppressants">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (7)</h3></li><li><a href="4778.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.1 Antiproliferative immunosuppressants</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a href="4779.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">AZATHIOPRINE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.1 Antiproliferative immunosuppressants</p></div></li><li><a href="4782.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.2 Corticosteroids and other immunosuppressants</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22immunosuppressants%22%22transplant+rejection%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>BNF for Children (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/100044.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Immunosuppressant therapy</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/4778.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.1 Antiproliferative immunosuppressants</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/4779.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">AZATHIOPRINE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.1 Antiproliferative immunosuppressants</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22immunosuppressants%22%22transplant+rejection%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/21175-p.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Immunosuppressants</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E34E3E0R0D2096.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Immunosuppressants</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_100044">Immunosuppressant therapy</h1><?highlighter on?><div id="pC" class="jN"><p>Immunosuppressants
are used to suppress rejection in organ transplant recipients and
to treat a variety of chronic inflammatory and autoimmune diseases.
Solid organ transplant patients are maintained on drug regimens, which
may include antiproliferative drugs (azathioprine or mycophenolate
mofetil), calcineurin inhibitors (ciclosporin or tacrolimus), corticosteroids,
or sirolimus. Choice is dependent on the type of organ, time after
transplantation, and clinical condition of the patient. Specialist
management is required and other immunomodulators may be used to initiate
treatment or to treat rejection. </p><div id="_201457"><div class="cN"><h3 class="cBP">Bioavailability</h3><p>Different formulations of the same immunosuppressant may vary
in bioavailability and to avoid reduced effect or excessive side-effects, it is important not to change formulation except on the advice of
a transplant specialist.</p></div></div><div class="cAZ"><h2>Impaired immune responsiveness</h2> <p class="cAX">Modification of tissue reactions caused by <span>corticosteroids</span> and other immunosuppressants may result in the rapid <i>spread
of infection</i>. <span>Corticosteroids</span> may suppress clinical signs of infection and allow diseases such
as septicaemia or tuberculosis to reach an advanced stage before being
recognised—<b>important: </b>for advice on
measles exposure, see <a title="BNF:target-block: normal immunoglobulin measles" href="202710.htm#_6539.2">section 14.5.1</a>, and
chickenpox (varicella) exposure, see <a title="BNF:monograph-family: Varicella–zoster" href="202721.htm#_202721">section 14.5.2</a>. For advice on the use of live
vaccines in individuals with impaired immune response, see <a title="target-block: contra-indications" href="6451.htm#_6451.4">section 14.1</a>. For general comments and warnings
relating to <span>corticosteroids</span> and immunosuppressants,
see <a title=" Glucocorticoid therapy" href="4255.htm#_4255">section 6.3.2</a>.</p></div><div id="_120500"><div class="cAZ" id="_100044.1"><h2>Pregnancy</h2> <p class="cAX">Transplant patients
immunosuppressed with <span>azathioprine</span> should not discontinue
it on becoming pregnant. However, there have been reports of premature
birth and low birth-weight following exposure to azathioprine, particularly
in combination with corticosteroids. Spontaneous abortion has
been reported following maternal or paternal exposure. Azathioprine is teratogenic in <i>animal</i> studies.</p> <p class="cAX"><span id="_100044.2">There is less experience of ciclosporin
in pregnancy but it does not appear to be any more harmful than azathioprine</span>. <span id="_100044.3">The use of these drugs
during pregnancy needs to be supervised in specialist units.</span> </p><div id="_100044.4"></div></div></div></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="4777.htm">Previous: 8.2 Drugs affecting the immune response</a> | <a class="top" href="100044.htm#">Top</a> | <a accesskey="]" href="4778.htm">Next: 8.2.1 Antiproliferative immunosuppressants</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>